Results 171 to 180 of about 6,897,562 (308)

The effects of low-molecular-weight fucoidan on the quality of frozen Litopenaeus vannamei. [PDF]

J Sci Food Agric
Lei X, Wang H, Sun J, Shi Y, Xu Z, Wu S, Ma Y, Liu S, He Y, Wang Q, Ren D.   +10 more
europepmc   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

Molecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim, Aurelie Genoux, Nadiia Zubchuk, Haoyang Zheng, Perla Salameh, Theo Ziegelmeyer, Fabien Dalonneau, Margot Rouchette, Christiane Oddou, Simona Miron, Helene Polveche, Adiilah Mamode Cassim, Carmen Garrido, Eleni Nikolakaki, Didier Auboeuf, Tao Jia, Sophie Zinn‐Justin, Beatrice Eymin   +17 more
wiley   +1 more source

Engineering dextranase for the directed preparation of low-molecular-weight dextran. [PDF]

Food Chem (Oxf)
Qin Y, Ren Y, Tong L, Liang G, Yuan Y, Meng L, Zhang H, Wang Q.   +7 more
europepmc   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Carol Ruff , 1998 [picture] /

, 1998
Title from caption on item.; Inscriptions: Larger print: "Carol Ruff 1998" - in pencil on reverse l.l. corner. "Photograph Greg Weight 1998" - in pencil on reverse l.r. corner. Smaller print: similar in ink.; Two prints from the same negative.; Condition:
Weight, Greg, 1946-
core  

Low-molecular-weight heparins in atrial fibrillation: clinical scenarios, limitations, and future perspectives. [PDF]

Front Pharmacol
Mędrek S, Zaborowska-Szmit M, Szmit S.
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

High molecular weight hyaluronan for treatment of chronic shoulder pain associated with glenohumeral arthritis

, 2011
Arnold J WeilNon-Surgical Orthopedics PC, Marietta, GA, USABackground: There is insufficient evidence to determine whether intra-articular injections may be effective for treatment of glenohumeral osteoarthritis.
Weil AJ
core  

Targetoid-like necrotic plaque after low-molecular-weight heparin injection. [PDF]

JAAD Case Rep
Morales FS, Cauliez A, Aubin F.
europepmc   +1 more source

Molecular Weight and Molecular Weight Distribution (1)

Sen'i Gakkaishi, 1976
openaire   +2 more sources